XML 41 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except for share and per share data) (USD $)
3 Months Ended 6 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Nov. 30, 2013
Nov. 30, 2012
Revenues {1}        
Products $ 376 $ 478 $ 618 $ 693
Services 1,038 1,194 2,172 2,359
Royalties from sale of patents 0 100 0 290
Total revenue 1,414 1,772 2,790 3,342
Products. 28 24 62 49
Services. 264 323 572 631
Total cost of revenue 292 347 634 680
Gross margin 1,122 1,425 2,156 2,662
Research and development expenses 304 323 639 567
Selling, general and administrative expenses 866 789 1,747 1,547
Gain on sale of product line (91) 0 (91) 0
Operating income 43 313 (139) 548
Interest expense 104 69 199 134
Other Income (17) (8) (28) (11)
Net income (loss) $ (44) $ 252 $ (310) $ 425
Basic and diluted net income (loss) per share: $ (0.05) $ 0.25 $ (0.35) $ 0.43
Weighted average common shares outstanding-basic 875,135 995,468 888,140 995,295
Weighted average number of common stock outstanding - diluted 875,135 997,751 888,140 996,572